João Quevedo Selected Research

BB Form Creatine Kinase

2/2010	Evaluation of brain creatine kinase activity in an animal model of mania induced by ouabain.
2/2008	Brain creatine kinase activity in an animal model of mania.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

João Quevedo Research Topics

Disease

73	Mania (Manias) 01/2022 - 05/2006
44	Sepsis (Septicemia) 01/2019 - 01/2005
42	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 06/2006
34	Cognitive Dysfunction 07/2022 - 01/2005
28	Inflammation (Inflammations) 03/2022 - 07/2010
24	Schizophrenia (Dementia Praecox) 01/2021 - 06/2006
23	Meningitis 01/2017 - 11/2009
20	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2017 - 11/2009
19	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2015 - 03/2006
17	Major Depressive Disorder (Major Depressive Disorders) 11/2021 - 04/2014
14	Mood Disorders (Mood Disorder) 01/2021 - 06/2006
11	Body Weight (Weight, Body) 01/2021 - 11/2008
9	Mental Disorders (Mental Disorder) 01/2022 - 07/2007
9	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2008
9	Bacterial Meningitis 04/2016 - 11/2009
7	Anhedonia 12/2018 - 04/2009
6	Decapitation 08/2015 - 01/2010
5	Sleep Deprivation 01/2022 - 01/2013
5	Maple Syrup Urine Disease 05/2018 - 05/2012
5	Obesity 05/2017 - 12/2011
5	Infections 01/2015 - 11/2009
5	Memory Disorders (Memory Loss) 10/2014 - 07/2007
5	Brain Injuries (Brain Injury) 12/2012 - 04/2010
4	Muscular Dystrophies (Muscular Dystrophy) 07/2022 - 08/2013
4	Dementia (Dementias) 01/2021 - 01/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 08/2012
4	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 07/2013
4	Necrosis 12/2017 - 10/2004
4	Delirium 01/2017 - 04/2011
4	Critical Illness (Critically Ill) 05/2014 - 04/2011
4	Depressive Disorder (Melancholia) 02/2013 - 09/2009

Drug/Important Bio-Agent (IBA)

40	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 06/2006
34	LithiumIBA 01/2020 - 06/2006
28	CytokinesIBA 01/2020 - 09/2007
25	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2021 - 05/2006
25	Valproic Acid (Depakote)FDA LinkGeneric 12/2019 - 06/2006
24	Ketamine FDA LinkGeneric 03/2022 - 04/2009
22	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021 - 05/2006
21	AntioxidantsIBA 01/2021 - 05/2006
20	Ouabain (G Strophanthin)IBA 01/2022 - 12/2009
20	EnzymesIBA 01/2021 - 03/2006
19	Methylphenidate (Ritalin)FDA LinkGeneric 10/2015 - 03/2006
18	Antidepressive Agents (Antidepressants)IBA 01/2022 - 04/2006
18	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 10/2006
16	salicylhydroxamic acid (SHAM)IBA 12/2013 - 01/2005
15	Proteins (Proteins, Gene)FDA Link 07/2022 - 03/2006
14	Biomarkers (Surrogate Marker)IBA 03/2022 - 12/2009
11	Biological ProductsIBA 01/2022 - 09/2008
11	Histone Deacetylase InhibitorsIBA 01/2021 - 06/2011
10	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 07/2007
10	Butyric Acid (Butanoic Acid)IBA 01/2018 - 12/2011
9	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2010
9	Nerve Growth Factor (NGF)IBA 12/2019 - 06/2006
9	InterleukinsIBA 01/2019 - 04/2010
9	Creatine Kinase (Creatine Phosphokinase)IBA 11/2014 - 02/2008
8	Pharmaceutical PreparationsIBA 11/2021 - 12/2011
8	Tamoxifen FDA LinkGeneric 01/2020 - 04/2011
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 01/2008
8	Dopamine (Intropin)FDA LinkGeneric 10/2014 - 09/2006
7	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 06/2011
7	ChemokinesIBA 01/2020 - 04/2010
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 06/2006
7	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 11/2009
6	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 12/2019 - 10/2006
6	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2017 - 04/2009
6	CorticosteroneIBA 01/2017 - 04/2009
6	AcetylcholinesteraseIBA 08/2015 - 08/2012
6	Citrate (si)-Synthase (Synthase, Citrate)IBA 12/2013 - 05/2007
6	SuspensionsIBA 03/2013 - 04/2010
5	KynurenineIBA 11/2021 - 09/2015
5	Protein Kinase CIBA 01/2020 - 02/2012
5	Neurotransmitter Agents (Neurotransmitter)IBA 12/2019 - 09/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2009
5	N-Methylaspartate (NMDA)IBA 01/2019 - 04/2009
5	Peroxidase (Myeloperoxidase)IBA 01/2018 - 04/2011
5	Adenosine Triphosphatases (ATPase)IBA 11/2017 - 09/2006
5	Thiobarbituric Acid Reactive SubstancesIBA 01/2016 - 12/2010
5	Deferoxamine (Desferal)FDA LinkGeneric 06/2015 - 10/2004
5	Acetylcysteine (Siran)FDA LinkGeneric 06/2015 - 10/2004
5	Superoxide DismutaseIBA 05/2015 - 03/2006
5	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2013 - 01/2005
5	CannabidiolIBA 12/2012 - 12/2010
4	Imipramine (Janimine)FDA LinkGeneric 01/2022 - 12/2007
4	Cholinergic Agents (Cholinergics)IBA 11/2018 - 09/2013
4	Branched-Chain Amino AcidsIBA 05/2018 - 05/2012
4	Interleukin-10 (Interleukin 10)IBA 09/2015 - 10/2014
4	Dihydrotachysterol (AT 10)IBA 01/2015 - 01/2010
4	ATPase Inhibitory ProteinIBA 11/2014 - 12/2009
4	CatalaseIBA 05/2014 - 03/2006
4	Therapeutic UsesIBA 08/2013 - 07/2008
4	LipidsIBA 07/2013 - 10/2004
4	Clindamycin (Cleocin)FDA LinkGeneric 09/2009 - 01/2005
3	Dystroglycans (Dystroglycan)IBA 07/2022 - 08/2013
3	Tryptophan (L-Tryptophan)FDA Link 01/2021 - 09/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 10/2006
3	Amyloid beta-PeptidesIBA 01/2021 - 02/2014
3	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 06/2012

Therapy/Procedure

23	Ligation 11/2017 - 01/2005
12	Therapeutics 01/2022 - 11/2009
8	Punctures 01/2015 - 01/2005